133 related articles for article (PubMed ID: 12185599)
1. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression.
Zhang Z; Wang Y; Herzog CR; Liu G; Lee HW; DePinho RA; You M
Oncogene; 2002 Aug; 21(38):5960-6. PubMed ID: 12185599
[TBL] [Abstract][Full Text] [Related]
2. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
3. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
4. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
5. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression.
Manenti G; Gariboldi M; Fiorino A; Zanesi N; Pierotti MA; Dragani TA
Cancer Res; 1997 Oct; 57(19):4164-6. PubMed ID: 9331067
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
Herzog CR; Lubet RA; You M
J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
[TBL] [Abstract][Full Text] [Related]
8. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
9. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
10. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
[TBL] [Abstract][Full Text] [Related]
11. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
[TBL] [Abstract][Full Text] [Related]
12. Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice.
Liu P; Wang Y; Vikis H; Maciag A; Wang D; Lu Y; Liu Y; You M
Nat Genet; 2006 Aug; 38(8):888-95. PubMed ID: 16862160
[TBL] [Abstract][Full Text] [Related]
13. The INK4a/ARF locus and melanoma.
Sharpless E; Chin L
Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
[TBL] [Abstract][Full Text] [Related]
14. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
15. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
[TBL] [Abstract][Full Text] [Related]
16. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice.
Festing MF; Lin L; Devereux TR; Gao F; Yang A; Anna CH; White CM; Malkinson AM; You M
Genomics; 1998 Oct; 53(2):129-36. PubMed ID: 9790761
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines.
Wang M; Lemon WJ; Liu G; Wang Y; Iraqi FA; Malkinson AM; You M
Cancer Res; 2003 Jun; 63(12):3317-24. PubMed ID: 12810665
[TBL] [Abstract][Full Text] [Related]
18. Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus.
Liu PY; Vikis H; James M; Lu Y; Wang DL; Liu HB; Wen WD; Wang Y; You M
Cancer Res; 2009 Aug; 69(15):6290-8. PubMed ID: 19622765
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
[TBL] [Abstract][Full Text] [Related]
20. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]